Last reviewed · How we verify
NCT05629572: i-STAT hs-TnI
Abbott i-STAT High Sensitivity Troponin I Study
trial testing i-STAT hs-TnI Cartridge Testing on i-STAT 1 and i-STAT Alinity in Myocardial Infarction in 3,697 participants. Completed in 11 March 2024.
6 February 2024
Quick facts
| Lead sponsor | Abbott Point of Care |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 3,697 |
| Start date | 2 November 2022 |
| Primary completion | 6 February 2024 |
| Estimated completion | 11 March 2024 |
| Sites | 28 locations across United States |
Drugs / interventions tested
- i-STAT hs-TnI Cartridge Testing on i-STAT 1 and i-STAT Alinity
Conditions studied
- Myocardial Infarction — all drugs for Myocardial Infarction →
Sponsor
Abbott Point of Care
Who can join
18 and older, any sex, with Myocardial Infarction. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this observational multi-center study is to evaluate the clinical performance of the i-STAT hs-TnI test (i-STAT High Sensitivity Troponin I) using the investigational i-STAT hs-TnI cartridge for the proposed intended use as an aid in the diagnosis and treatment of myocardial infarction (MI). The cartridge measures cardiac troponin I (cTnI) in whole blood or plasma samples using the i-STAT 1 Analyzer or i-STAT Alinity Instrument. Subjects presenting to the emergency department (ED) with chest discomfort or equivalent ischemic symptoms suggestive of Acute Coronary Syndrome (ACS) who are enrolled in this study will be asked to provide blood samples for testing.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Clinical Performance of a Novel Point-of-Care High-Sensitivity Cardiac Troponin I Assay.
Wu AHB, Mahler SA, House SL, Jortani SA, et al · · 2026 · cited 1× · PMID 41146629 · DOI 10.1093/jalm/jfaf152
Verify or expand the search:
- PubMed search for NCT05629572
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Myocardial Infarction
Currently open trials in the same condition.
- NCT07257198 — Aspirin-free Strategy With Ticagrelor in Patients With a Myocardial Infarction Treated Medically Alone · Phase 3 · recruiting
- NCT07402642 — Effect of Early Educational Intervention on Cardiovascular Risk Factors After Acute Coronary Syndrome · NA · recruiting
- NCT07301034 — A Research Study to Look at the Effect of Ziltivekimab on Plaque in the Blood Vessels of the Heart, Compared to Placebo, · Phase 3 · recruiting
- NCT07142265 — Evaluation of 1-Year Clinical Outcomes With Early Inclisiran Initiation in Post-MI Patients · recruiting
- NCT07138911 — Effect of Home-based Exercise Plan Mediated by Use of Digital Health App on Kinesiophobia and Functional Capacity · NA · recruiting
Other Abbott Point of Care trials
Trials by the same sponsor.
- NCT06295835 — Method Comparison Study for Measuring Potassium (K) and Ionized Calcium (iCa) in Blood · NA · completed
- NCT06291493 — Precision Study Measuring Potassium (K) in Capillary Specimens · NA · completed
- NCT07382076 — Clinical Evaluation of the i-STAT ACTpro Cartridge in an Adult Population · active not recruiting
- NCT04171960 — Clinical Evaluation of the i-STAT TBI Test · completed
- NCT02897154 — Clinical Evaluation of i-STAT Analyzer Glucose, Hematocrit and Sodium for Capillary Samples · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05629572 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Abbott Point of Care
- Last refreshed: 19 September 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05629572.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing